Back to Treatments
Transplant & Hematology

Stem Cell Transplant for Leukemia

白血病干细胞移植

Duration

4-6 weeks inpatient for transplant; 100 days close monitoring

Recovery

100 days for initial engraftment period; 6-12 months for immune reconstitution

$

Savings

~84% vs US

Price Comparison
China$30,000 - $60,000
$45,000
United States$150,000 - $400,000
$275,000
Save approximately 84%

Average savings compared to US prices

About This Treatment

Allogeneic hematopoietic stem cell transplantation (HSCT) for acute and chronic leukemias using matched related, unrelated, or haploidentical donors. China's HSCT centers, particularly Peking University People's Hospital under the Beijing Protocol, have pioneered haploidentical transplantation techniques that achieve outcomes comparable to matched unrelated donor transplants, dramatically expanding the donor pool and reducing wait times for patients without a matched sibling.

Procedure Steps
1

Pre-Transplant Evaluation & Donor Search

Disease restaging, organ function assessment, HLA typing, donor selection (sibling, unrelated, or haploidentical), and donor workup

Duration: 2-4 weeks
2

Conditioning Chemotherapy

Myeloablative or reduced-intensity conditioning regimen to eliminate residual leukemia and create space for donor cells

Duration: 5-10 days
3

Stem Cell Infusion

Infusion of donor peripheral blood stem cells or bone marrow, with GVHD prophylaxis initiated (cyclosporine, methotrexate, or PTCy)

Duration: 1 day
4

Engraftment & GVHD Management

Monitoring for neutrophil and platelet engraftment, infection prophylaxis, GVHD surveillance, and chimerism testing

Duration: 3-6 weeks inpatient + 100 days outpatient
Benefits
  • Pioneering haploidentical transplant expertise (Beijing Protocol)
  • Outcomes comparable to matched unrelated donor transplants
  • Expanded donor pool means nearly every patient has a donor option
  • Cost savings of 70-80% compared to US transplant programs
Considerations
  • Graft-versus-host disease (acute and chronic)
  • Severe infections during neutropenic period
  • Graft failure or relapse of leukemia
  • Long-term effects including infertility and secondary cancers

Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.